Clinical prospective study on the prognosis of postoperative recurrence of bladder cancer markers of urine sCD14

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ORC-13003153

Enrollment

Unknown

Registered

2013-04-09

Start date

2013-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder tumor

Interventions

one cohort:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All time to come to our hospital in the pathological diagnosis of bladder cancer and surgery patients are included in the study.

Exclusion criteria

Exclusion criteria: (1) the tumor patients with distant metastasis has occurred; (2) has a history of bladder tumor before; (3) pregnant and lactation women; (4) psychiatric patients; (5) foreign population; (6) of the floating population, and not willing to accept with the visitor.

Design outcomes

Primary

Measure	Time frame
SCD14 urinary albumin concentration;	—

Secondary

Measure	Time frame
gender;race;neoplasm staging;Tumor grade;Tumor size;Tumor types;Tumor number;operation method;Postoperative adjuvant radiation and chemotherapy;Postoperative bladder perfusion;	—

Countries

China

Contacts

Public ContactWeifeng He

Heweifeng7412@yahoo.com.cn+86 023 68754149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026